Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation

Migliore A, Corio M, Perrini MR, Rivoiro C, Jefferson T
Record ID 32016000855
English
Authors' objectives: The scope of the present assessment was to answer the question if in adults with chronic primary (degenerative) or secondary (functional) MR who are at high surgical risk or non-surgical candidates, transcatheter MV repair by implantable device is more effective, safe and cost-effective than pharmacological treatment (when indicated) with/without cardiac resynchronisation therapy (CRT).
Authors' recommendations: The available evidence did not allow any final statement to be reached on the relative effectiveness of transcatheter implantable devices for MV repair (CARILLON® Mitral Contour System® and MitraClip® System) in adults with moderate-to-severe and severe chronic MR. The two economic studies (one for CARILLON® Mitral Contour System® and one for MitraClip®System) included in the analysis showed that, in patients with moderate to severe and severe MR at high surgical risk or not eligible for surgery, the two devices are cost-effective compared to conventional/optimal medical treatment.
Details
Project Status: Completed
Year Published: 2016
URL for published report: http://www.salute.gov.it/imgs/C_17_pagineAree_1202_listaFile_itemName_11_file.pdf
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Italy
MeSH Terms
  • Humans
  • Adult
  • Cardiac Surgical Procedures
  • Heart Valve Prosthesis Implantation
  • Mitral Valve
  • Mitral Valve Insufficiency
  • Prostheses and Implants
Contact
Organisation Name: The Italian National Agency for Regional Health Services (Agenas)
Contact Address: Agenzia nazionale per i servizi sanitari regionali, Via Puglie 23, 00187 Rome, Italy
Contact Name: hta@agenas.it
Contact Email: hta@agenas.it
Copyright: Italian Ministry of Health and Agenas
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.